A Changing of the Guard: Robert P. Mauch to Become CEO in October 2024


Steven H. Collis, who currently holds the position, will transition to executive chair of the board.

Robert P. Mauch, PharmD, PhD, Cencora

Robert P. Mauch, PharmD, PhD, Cencora

Steven H. Collis will retire as president and CEO of Cencora, shifting to the role of executive chair of the company’s board of directors, effective Oct. 1, 2024. Following that date, Robert P. Mauch, PharmD, PhD, Cencora’s current COO, will succeed Collis as president and CEO. He’ll also be appointed onto the drug wholesaler’s board, effective that same day.

“Steve’s 30-year career at Cencora has been characterized by purpose-driven leadership, delivering phenomenal growth in domestic and international markets, diversification of the business, and the successful launch of a global brand that positions the company for even greater success. Since Steve’s appointment as CEO in 2011, Cencora has delivered tremendous financial growth, with the company’s annual revenue more than tripling to exceed $250 billion,” said Mark Durcan, Cencora’s lead independent director. “Under his leadership, Cencora has grown into the global healthcare leader it is today with its 46,000 team members spanning over 50 countries.

Collis has no regrets of his leadership tenure with the company. In fact, he has great optimism in what his successor brings to the table.

“In my 30 years with Cencora, including 13 years as CEO, it has been my privilege to lead our company as we have delivered robust growth, made strategic investments and forged key partnerships,” he commented. “I am particularly proud of the position we are in today where Cencora is characterized by our strong industry leadership position, intellectual confidence, and best-in-class talent and customer relationships.

“Together, the Cencora team has built extraordinary relationships across our industry, expanded the breadth of our innovative pharmaceutical solutions and grown our global footprint, furthering our ability to advance our purpose of creating healthier futures. Bob and I have worked closely for nearly two decades, and I am proud that he will be the third CEO in our company’s 23-year history.”


Cencora Announces Leadership Succession Plan. Cencora. March 12, 2024. Accessed March 13, 2024. https://www.cencora.com/newsroom/press-releases/cencora-announces-leadership-succession-plan

Related Videos
© 2024 MJH Life Sciences

All rights reserved.